Advertisement
News
Subscribe to MDT Magazine News

Talecris, Grifols delay closing of $3.4B deal

March 4, 2011 7:45 am | by The Associated Press | Comments

Talecris Biotherapeutics Holdings Corp. said Friday the closing of its sale to Spanish health care company Grifols SA is being delayed by almost three months.Grifols agreed to buy Talecris in June for $3.4 billion, or $26.16 per share in cash and stock. The companies had said they expected the...

Epizyme moving HQ to Vassar Street

March 4, 2011 7:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge biotech Epizyme Inc. plans to move its headquarters from Memorial Drive to 325 Vassar Street, doubling its space.

Topamax (topiramate): Label Change - Risk For Development of Cleft Lip and/or Cleft Palate in Newborns

March 4, 2011 7:30 am | by U.S. Food & Drug Administration | Comments

Increased risk of oral clefts in infants born to women treated with Topamax (topiramate) during pregnancy.

TOPICS:
Advertisement

Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map

March 4, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., March 4, 2011 /- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs. Facing an ever-changing launch landscape,...

TOPICS:

ICAP Ocean Tomo Announces Four Patent Sets From Oxford Instruments - Each Represents an Important Advancement in Technology

March 4, 2011 6:34 am | by Bio-Medicine.Org | Comments

CHICAGO, March 4, 2011 /- The Oxford Instruments patents will be auctioned off at ICAP Ocean Tomo's Spring 2011 Live IP Auction on March 31, 2011 in New York City. Oxford Instruments has determined that these patents are not strategic for its ongoing business. The lots include: a concept...

TOPICS:

FDA: Risk of Oral Birth Defects in Children Born to Mothers Taking Topiramate

March 4, 2011 6:33 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., March 4, 2011 /PRNewswire-USNewswire/ -- New data suggest that the drug Topamax (topiramate) and its generic versions increase the risk for the birth defects cleft lip and cleft palate in babies born to women who use the medication during pregnancy, the U.S. Food and...

TOPICS:

Surgeon General, AACR Leaders Urge Increased Investment in Research to Tackle America's Tobacco Epidemic

March 4, 2011 6:33 am | by AACR | Comments

WASHINGTON, D.C. - Stemming the tide of tobacco-related deaths and suffering and promoting public health will require renewed control efforts and further research to better understand initiation, addiction and the countless harmful effects of tobacco. These points were emphasized by U.S....

TOPICS:

Cerus 4Q loss narrows on revenue boost

March 4, 2011 5:45 am | by The Associated Press | Comments

Biotechnology company Cerus Corp. reported a smaller fourth-quarter loss on higher revenue.Cerus makes the Intercept Blood System, which inactivates blood-borne pathogens in donated blood used for transfusions.Claes Glassell, its president and CEO, said he expects slower revenue growth this...

Advertisement

Davol XenMatrix Surgical Graft: Class I Recall - Elevated Endotoxin Levels(2)

March 4, 2011 5:31 am | by U.S. Food & Drug Administration | Comments

Endotoxins in product can cause serious illness, at times fatal.

TOPICS:

Davol XenMatrix Surgical Graft: Class I Recall - Elevated Endotoxin Levels

March 4, 2011 5:30 am | Comments

Endotoxins in product can cause serious illness, at times fatal.

PennyAuthority.com Morning Alerts: Royal Energy, Pacific Ethanol, EnergyConnect Group, Kunekt, Net Savings Link, AppTech Corp, Amerilithium Corp.

March 4, 2011 4:45 am | by The Associated Press | Comments

PennyAuthority.com (http://pennyauthority.com/) is a premier source for microcap research - providing a wide range of due diligence and investment insight on stocks all over the market. PennyAuthority.com (http://pennyauthority.com/) Investment Report primary focus is to alert our valued...

Cardica Receives European CE Mark for Initial Microcutterâ„¢ Surgical Cutting and Stapling Device

March 4, 2011 4:34 am | by Bio-Medicine.Org | Comments

REDWOOD CITY, Calif., March 4, 2011 /- Cardica, Inc. (Nasdaq: CRDC ) today announced that an initial Microcutter™ surgical cutting and stapling device developed by Cardica has received CE Mark certification.  As an integral part of the multi-step CE marking process, Cardica has...

TOPICS:

IBM Business Analytics Software Helps BJC Healthcare and Washington University Improve Healthcare Through Better Research

March 4, 2011 4:33 am | by IBM | Comments

IBM today announced that BJC Healthcare (BJC) and Washington University School of Medicine (WUSM) are using IBM business analytics software to quickly extract key data from more than 50 million documents in medical records, speeding up research to ultimately provide better care for...

TOPICS:

MRI Improvements Show Promise for Myocardial Infarction

March 4, 2011 4:33 am | by Diagnostic Imaging | Comments

Refinements in MRI technique continue to show promise in clarifying the nature and extent of damage of myocardial infarction. Take for example teams from Munich, Germany presenting this week at ECR 2011, who have been finding ways around the problem of adapting inversion time to the...

TOPICS:

Ultrasound Elastography Developments Lead to Increased Sensitivity of Malignant Nodes

March 4, 2011 4:33 am | by Diagnostic Imaging | Comments

Ultrasound elastography is shown to raise sensitivity by 24 percent for preoperative assessment of axillary metastases in suspected breast cancer. Meanwhile, microbubbles identify sentinel lymph nodes, minimizing operations, according to researchers presenting at ECR 2011.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading